PUMA BIOTECHNOLOGY, INC. Financial Ratios
PBYI|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
DuPont ROE Decomposition (FY2025)
Return on Equity
23.4%
Profit Margin
9.2%
Net Income / Revenue
Asset Turnover
1.09
Revenue / Total Assets
Equity Multiplier
2.35
Total Assets / Equity
Composite: 23.4% (reported: 23.4%)
Profitability
Liquidity
Current Ratio
2.00
Quick Ratio
1.93
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
1.09
Inventory Turnover
11.37
Days Sales Outstanding
83 days
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
-2.5%
-9.9pp YoY
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.